ArticleJournal of experimental & clinical cancer research : CR2009

Combination of p53AIP1 and survivin expression is a powerful prognostic marker in non-small cell lung cancer.

Shin-ichi Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.